Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults
Clinical Pharmacology in Drug Development · 2024
DOI: 10.1002/cpdd.1396 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, 2024. Verfasst von Huizi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanxi Medical University, Taiyuan, SX, China. Hauptthemen laut MEDLINE: Area Under Curve, Calcium Channel Blockers, Cross-Over Studies, Delayed-Action Preparations. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Nifedipine is a potent antihypertensive medication classified as a dihydropyridine calcium channel blocker. The objective of this trial was to assess the bioequivalence of a 30‐mg nifedipine controlled‐release tablet and a reference drug in a cohort of healthy Chinese individuals. Two independent open‐label, randomized, single‐dose, crossover studies were conducted, 1 under fasting conditions (N = 44, with 1 participant dropping out midway) and the other under fed conditions (N = 44, with 4 participants dropping out midway). Plasma concentrations of nifedipine were determined using liquid chromatography‐mass spectrometry, and pharmacokinetic (PK) parameters were calculated using noncompartmental analysis with Phoenix WinNonlin 8.0 software. In both fasting and fed studies, reasonable bioequivalence was observed for the PK parameters of both the test product and the reference drug. A good safety profile was demonstrated for both the test product and reference drug, with no serious adverse events reported, and both were similarly well tolerated. An important observation with food coadministration was that systemic exposure to nifedipine (based on area under the curve, AUC 0‐∞ ) was reduced by approximately 12%. The bioequivalence of the test product and reference drug under fasting/fed conditions in healthy subjects in China was demonstrated by the study results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanxi Medical University, Taiyuan, SX, China.
- Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, SX, China.
Zitieren
APA
Zhang, H., Wang, S., Wang, H., Zhi, T., Ren, J., Wang, Y., Yao, Z., Zhang, P., Ye, N., & Zhang, R. (2024). Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1396
Vancouver
Zhang H, Wang S, Wang H, Zhi T, Ren J, Wang Y, et al. Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults. Clinical Pharmacology in Drug Development. 2024. doi:10.1002/cpdd.1396
BibTeX
@article{Zhang2024,
author = {Zhang, Huizi and Wang, Siyang and Wang, Hongxia and Zhi, Tingting and Ren, Jian and Wang, Yanhui and Yao, Zhiqing and Zhang, Pan and Ye, Naobei and Zhang, Ruiqin},
title = {Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults},
journal = {Clinical Pharmacology in Drug Development},
year = {2024},
doi = {10.1002/cpdd.1396}
}
EUVIMED